Search

Author/Creator Sander, Clare

1. An open label trial of nemiralisib, an inhaled PI3 kinase delta inhibitor for the treatment of Activated PI3 kinase Delta Syndrome. (April 2023)

Authors:
Begg, Malcolm; Amour, Augustin; Jarvis, Emily; Tang, Teresa; Franco, Sara Santos; Want, Andrew; Beerahee, Misba; Fernando, Disala; Karkera, Yakshitha; Sander, Clare; Southworth, Thomas; Singh, Dave; Clark, Jonathan; Nejentsev, Sergey; Okkenhaug, Klaus; Condliffe, Alison; Chandra, Anita; Cahn, Ant...
Journal:
Pulmonary pharmacology & therapeutics
Issue:
Volume 79(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Oseltamivir is protective for in-patient mortality in PCR confirmed influenza B and influenza A(H3N2) infections in an historic cohort of 1, 048 patients hospitalised during the 2016-17 and 2017-18  influenza seasons. Issue 3 (March 2023)

Authors:
Reacher, Mark; Warne, Ben; Verlander, Neville Q.; Popay, Ashley; Reeve, Lucy; Jones, Nicholas K.; Ranellou, Kyriaki; Sithole, Nyaradzai; Carpenter, Rory; Everden, Angharad; Jarman, Elizabeth; Khalid, Ali; Lam, Kyle; Myers, Chloe; Ren, Shuhui; Rolfe, Kathryn J; Sutton, Tommy; Christou, Silvana; Wr...
Journal:
Journal of infection
Issue:
Volume 86:Issue 3(2023)
Page Start:
256
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search